December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S (NY: NVO )

72.83 USD +0.31 (+0.43%)
Official Closing Price Updated: 6:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
Is Sanofi's Stock a Buy?
With new promising results for its diabetes drug, is Sanofi a good investment right now? 
Tags Market News NVO SNY
From Motley Fool
This Biotech With 456% Growth In 2019 Just Gained A Price-Target Boost
Arrowhead Pharmaceuticals grabbed an upgrade Friday as ARWR stock has rocketed 144% since October on enthusiasm for the biotech company's RNAi platform. ARWR stock is 87% above a buy point. 
From Investor's Business Daily
Is CRISPR Therapeutics the Best Gene-Editing Stock Right Now?
Following strong results for its flagship CTX001 drug, should you add CRISPR to your portfolio? 
Tags EDIT BLUE Market News
From Motley Fool
Advanced Medical Technologies Help Stem the Evergrowing Spread of Ailments
FinancialBuzz.com News Commentary 
From PR Newswire
PPH's Holdings Imply 12% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
19 Healthcare Stocks Moving In Friday's Pre-Market Session
Gainers Viveve Medical, Inc. (NASDAQ: VIVE) shares rose 121.7% to $4.81 during Friday's pre-market session. The market value ... 
Tags General Trading Ideas SNCA
From Benzinga
With A Rebrand And A New App, Will WW International Rebound In 2020?
Last week, Weight Watchers International rolled out myWW, offering members a customized approach to weight management. But will its new program and its rebranding effort help it recover from slimmer... 
Tags Market News NVO WW
From Motley Fool
Missed the 310% Rise of Arrowhead Pharmaceuticals? Keep an Eye On This Competitor
This early-stage biopharma is developing a promising gene-silencing pipeline that's beginning to turn heads. 
Tags ARWR JNJ RHHBY
From Motley Fool
13 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) stock moved upwards by 41.0% to $0.31 during Wednesday's pre-market ... 
Tags Healthcare Stocks Pre/Market Movers ACB DFFN
From Benzinga
The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags OCGN AGEN AXNX
From Benzinga
New "Cities Changing Diabetes" public-private partnership in Philadelphia mobilizing against city's diabetes epidemic
Emerging research begins to identify neighborhood characteristics that could impact the incidence of and vulnerability to chronic disease 
From PR Newswire
The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags KPTI SRTS DFFN
From Benzinga
Best & Worst ADRs - Monday, Nov. 18
The top-ranked sectors in the ADR universe this week are services, healthcare, and industrial goods. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Here's Why Dicerna Pharmaceuticals Jumped as Much as 22.1% Today
The small-cap biopharma inked a deal with a major pharmaceutical company, its second in three weeks. 
Tags DRNA NVO Market News
From Motley Fool
Benzinga's Top Upgrades, Downgrades For November 18, 2019
Upgrades For Anheuser-Busch InBev SA/NV (NYSE: BUD), Redburn upgraded the stock from Sell to Neutral. For the third quarter, ... 
Tags WRK PQG ANCN
From Benzinga
4 Big Drugmakers To Bet On After A Great Earnings Season
New drugs and label expansions of blockbuster drugs drove the top line of most of the big shots backed by higher demand, which countered headwinds from generic/biosimilar competition for older... 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags TNXP LPCN Trading Ideas
From Benzinga
5 Healthcare Stocks Moving In Monday's Pre-Market Session
Gainers Innate Pharma, Inc. (NASDAQ: IPHA) shares rose 3.8% to $6.55 during Monday's pre-market session. Teva Pharmaceutical ... 
Tags Market News Markets TEVA
From Benzinga
3 Top Diabetes Stocks to Watch in November
There are some highly promising diabetes treatments entering the market that investors should know about. 
Tags TNDM NVO LLY
From Motley Fool
Novo Nordisk A/S (NVO) Q3 2019 Earnings Call Transcript
NVO earnings call for the period ending September 30, 2019. 
Tags Market News NVO
From Motley Fool
26 Stocks Moving in Friday's Pre-Market Session
Gainers California Resources Corporation (NYSE: CRC) shares rose 29% to $7.21 in pre-market trading after reporting strong Q3 ... 
Tags AXNX AIG Movers
From Benzinga
Earnings Scheduled For November 1, 2019
Companies Reporting Before The Bell Booz Allen Hamilton Holding Corporation (NYSE: BAH) is projected to report quarterly earnings ... 
Tags LYB Earnings Scheduled BABA
From Benzinga
The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags Market News BMY NTLA
From Benzinga
The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags NVO EXAS Earnings
From Benzinga
The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags AMGN Biotech XBI
From Benzinga
More Earnings And A Fed Decision In Week Four Of The WeTrader Competition
Today marks the start of the fourth round of the WeTrader Competition, hosted by the zero-commission online trading platform ... 
Tags KHC Webull TMUS
From Benzinga
Better Buy: Abbott Laboratories vs. Novo Nordisk
Which stock wins in a battle between these two healthcare giants? 
Tags ABT ABBV NVO
From Motley Fool
The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags DFFN ABEO FDA
From Benzinga
Don’t Sleep on These 2 Pharmaceutical Stocks
Wall Street hasn't been impressed by the makers of Humira and Trulicity lately, but their long-term prospects look stronger. 
Tags Market News LLY NVO
From Motley Fool
No Memorial Today
Our sold stocks are crashing and our bought stocks climbing! We have reports from the USA, Japan, Israel, Denmark, and Canada, and that's only about pharmaceuticals. We also have exciting news about... 
Tags Pharma/Biotech Technology Financial
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.